Management of Hepatitis B Virus and Hepatitis C Virus Infections in Patients with Cancer Receiving Immune Checkpoint Inhibitors
ABSTRACT: Background: Patients with cancer with hepatitis B virus (HBV) or hepatitis C virus (HCV) infection are excluded from manycancer clinical trials of immune checkpoint inhibitors (ICIs). Therefore, data are limited regarding the management of HBV and HCV infectionsin patients with cancer trea...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Innovative Healthcare Institute
2024-05-01
|
| Series: | Journal of Immunotherapy and Precision Oncology |
| Assuntos: | |
| Acceso en liña: | https://jipo.org/doi/pdf/10.36401/JIPO-23-28 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|